Information Provided By: 
Fly News Breaks for January 7, 2016
GMED
Jan 7, 2016 | 07:55 EDT
JMP Securities analyst David Turkaly noted Globus Medical's initial 2016 guidance was mixed, coming in a bit below expectations on the top line and a bit above on the bottom line, but added that the company's view may once again be slightly conservative. The analyst keeps an Outperform rating and $31 price target on Globus shares.
News For GMED From the Last 2 Days
There are no results for your query GMED
